| 1 |
Zhang Q, Wu Z, Zhang Z, et al. Efficacy and effect of free treatment on multidrug-resistant tuberculosis[J]. Exp Ther Med, 2016, 11(3): 777-782.
|
| 2 |
任成山，林 辉，杨仕明. 结核病的流行特征与耐多药的窘迫及其策略[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 269-274.
|
| 3 |
杨 松，郭建琼，严晓峰. 抗结核药物性肝损伤发生机制的研究进展[J]. 中华结核和呼吸杂志，2019, 42(5): 378-381.
|
| 4 |
Germani G, Battistella S, Ulinici D, et al. Drug induced liver injury: from pathogenesis to liver transplantation[J]. Minerva Gastroenterol (Torino), 2021, 67(1): 50-64.
|
| 5 |
Xu H, Zhang Y, Ren J. ALDH2 and stroke: asystematic review of the evidence[J]. Adv Exp Med Biol, 2019, 1193: 195-210.
|
| 6 |
Zheng Y, Ning C, Zhang X, et al. Association between ALDH-2 rs671 and essential hypertension risk or blood pressure levels: asystematic review and meta-analysis[J]. Front Genet, 2020, 11: 685.
|
| 7 |
Chen J, Huang W, Cheng CH, et al. Association between aldehyde dehydrogenase-2 polymorphisms and risk of alzheimer′sdisease and parkinson′sdisease: ameta-analysis based on 5，315 individuals[J]. Front Neurol, 2019, 10: 290.
|
| 8 |
中华医学会结核病学分会. 《肺结核诊断和治疗指南(2001年订)》[J]. 内科危急重症杂志，2002, 8(4): 225-229.
|
| 9 |
于乐成，茅益民，陈成伟．《药物性肝损伤诊治指南》[J]. 实用肝脏病杂志，2017, 20(2): 257-274.
|
| 10 |
沈 弢，黄 昕，王誉雅，等. 我国药物性肝损伤流行病学研究现状[J]. 临床肝胆病杂志，2018, 34(6): 1152-1155.
|
| 11 |
Xu N, Yang JX, Yang J. Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China[J]. Eur J Hosp Pharm, 2020, ejhpharm-2020-002433.
|
| 12 |
Seo W, Gao Y, He Y, et al. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles[J]. J Hepatol, 2019, 71(5): 1000-1011.
|
| 13 |
Zhang R, Wang J, Xue M, et al. ALDH2-The genetic polymorphism and enzymatic activity regulation: their epidemiologic and clinical implications[J]. Curr Drug Targets, 2017, 18(15): 1810-1816.
|
| 14 |
Wang LS, Wu ZX. ALDH2 and cancer therapy[J]. Adv Exp Med Biol, 2019, 1193: 221-228.
|
| 15 |
Ushijima K, Ogami C, Tsuji Y, et al. Presence of the aldehyde dehydrogenase 2 variant ALDH2*2 considerably increases EC50 of nitroglycerin[J]. Eur J Clin Pharmacol, 2021, 77(3): 431-433.
|